BackMedicus Sciences Acquisition Overview

Medicus Sciences Acquisition Total Liabilities

Medicus Sciences Acquisition's total liabilities is $3.9M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.87M
↓ 52.69% YoYΔ $-4.31M vs prior year quarter

Peer average

Loading

Medicus Sciences Acquisition Total Liabilities History

Loading

Medicus Sciences Acquisition vs. peers: Total Liabilities Comparison

Loading

Medicus Sciences Acquisition Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Medicus Sciences Acquisition (MSAC) FAQ

Medicus Sciences Acquisition (MSAC) currently reports a total liabilities of $3.9M as of September 2022. That compares with $8.2M in the prior-year period — down 52.7% year over year. Use the charts on this page to explore Medicus Sciences Acquisition's total liabilities history and peer comparisons.

Medicus Sciences Acquisition's total liabilities decreased from $8.2M to $3.9M — a 52.7% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medicus Sciences Acquisition reported $3.9M in total liabilities as of September 2022. That compares with $8.2M in the prior-year period — down 52.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $3.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Medicus Sciences Acquisition, and consider following MSAC for alerts when major investors trade the stock.